Can a common cholesterol pill flush out 'forever chemicals' from veterans' bodies?

NCT ID NCT07592858

Not yet recruiting Disease control Sponsor: University of Rhode Island Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a drug called colesevelam, normally used for high cholesterol, can help lower levels of PFAS (often called 'forever chemicals') in the blood of veterans. About 50 veterans with high PFAS levels will receive either the drug or a placebo for a period, and researchers will measure changes in their blood and cholesterol. The goal is to find a safe way to reduce these chemicals and improve health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BURN PIT EXPOSURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypercholesterolemia hyperlipidemia PFAPA syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BURN PIT EXPOSURE ENVIRONMENTAL EXPOSURES FOREVER CHEMICALS HYPERLIPIDEMIA (E.G., HYPERCHOLESTEROLEMIA) HYPERLIPIDEMIAS, HYPERCHOLESTEROLEMIA, MIXED DYSLIPIDEMIA MILITARY EXPOSURE OCCUPATIONAL EXPOSURE TO CHEMICALS PFAS

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Robley Rex VA Medical Center

Louisville, Kentucky, 40245, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
VA Maine Healthcare System

Augusta, Maine, 04330, United States
VA Maine Healthcare System

Augusta, Maine, 04330, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.